Capital

505, 2021

Entheon Biomedical Uplists on OTCQB Venture Market

VANCOUVER, B.C.– Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: "1XU1"), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces it has been ...

Go to Top